HighTower Advisors
IPXL

HighTower Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History

HighTower Advisors’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-41,193
Closed -$1.24M – 1699
2014
Q2 		$1.24M Buy
41,193
+2,788
+7% +$75.2K 0.02% 736
2014
Q1 		$1.01M Buy
38,405
+6,347
+20% +$159K 0.02% 741
2013
Q4 		$806K Buy
32,058
+3,288
+11% +$73.3K 0.02% 782
2013
Q3 		$593K Buy
+28,770
New +$594K 0.01% 790

Other funds holding IPXL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

HighTower Advisors's IPXL Position: Q3 2014 in Review

HighTower Advisors sold out of Impax Laboratories, Inc. (IPXL) in Q3 2014, closing a stake of 41,193 shares — an estimated $1.24M sold.

HighTower Advisors first reported a position in IPXL in Q3 2013 and held it in 4 quarters. The position peaked at $1.24M in Q2 2014. 162 funds tracked by Wall St. Rank hold IPXL as of Q3 2014.

  • HighTower Advisors reported no remaining Impax Laboratories, Inc. position as of Q3 2014 after selling out during the quarter.
  • HighTower Advisors sold 41,193 Impax Laboratories, Inc. shares in Q3 2014, an estimated $1.24M.
  • HighTower Advisors first reported a position in Impax Laboratories, Inc. in Q3 2013 and held it in 4 quarters.
  • HighTower Advisors's Impax Laboratories, Inc. position peaked at $1.24M in Q2 2014.
  • 162 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2014.

Based on HighTower Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.